Literature DB >> 15936902

Spi-1 and Spi-B control the expression of the Grap2 gene in B cells.

Lee Ann Garrett-Sinha1, Ping Hou, Duncheng Wang, Brian Grabiner, Elizabeth Araujo, Sridhar Rao, Theodore J Yun, Edward A Clark, M Celeste Simon, Marcus R Clark.   

Abstract

The Ets family members Spi-1 and Spi-B have been implicated in the regulation of genes important for B cell antigen receptor (BCR) signaling. Mice deficient in Spi-B exhibit reduced B cell proliferation in response to BCR cross-linking and impaired T cell-dependent immune responses. This defect is exacerbated in the presence of Spi-1 haplo-insufficiency (Spi1+/- SpiB-/-). Tyrosine phosphorylation and calcium mobilization induced by BCR engagement is diminished in Spi1+/- SpiB-/- B lymphocytes, although many key BCR signaling proteins are expressed, suggesting that Spi-1 and Spi-B regulate expression of additional, unidentified signaling molecules. We now demonstrate that expression of the adaptor protein Grap2 is impaired in Spi1+/- SpiB+/- and Spi1+/- SpiB-/- B lymphocytes. Analysis of two alternate murine Grap2 promoters revealed a functionally important Spi-1 and Spi-B DNA binding element located in the downstream promoter. Ectopic expression of Grap2 in Grap2-deficient B cells reduced the recruitment of BLNK to Igalpha and the phosphorylation of specific substrates. Regulation of BLNK recruitment was dependent upon the Grap2 proline-rich domain, while modulation of phosphorylation was dependent upon both the proline-rich and SH2 domains. These data indicate that Spi-1 and Spi-B directly regulate the expression of Grap2 and that Grap2 functions to modulate BCR signaling, but that reduced Grap2 expression is unlikely to account for the BCR signaling defects observed in Spi1+/- SpiB-/- B cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15936902     DOI: 10.1016/j.gene.2005.04.009

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

1.  Transgenic expression of Spi-C impairs B-cell development and function by affecting genes associated with BCR signaling.

Authors:  Xiang Zhu; Brock L Schweitzer; Eric J Romer; Courtney E W Sulentic; Rodney P DeKoter
Journal:  Eur J Immunol       Date:  2008-09       Impact factor: 5.532

2.  Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression.

Authors:  Heike Schmidlin; Sean A Diehl; Maho Nagasawa; Ferenc A Scheeren; Remko Schotte; Christel H Uittenbogaart; Hergen Spits; Bianca Blom
Journal:  Blood       Date:  2008-06-13       Impact factor: 22.113

3.  The Ets factor Spi-B is a direct critical target of the coactivator OBF-1.

Authors:  Boris Bartholdy; Camille Du Roure; Alain Bordon; Dianne Emslie; Lynn M Corcoran; Patrick Matthias
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-21       Impact factor: 11.205

4.  Transcription factor Spi-B binds unique sequences present in the tandem repeat promoter/enhancer of JC virus and supports viral activity.

Authors:  Leslie J Marshall; Lisa Dunham; Eugene O Major
Journal:  J Gen Virol       Date:  2010-09-08       Impact factor: 3.891

5.  Tracking Differential Gene Expression in MRL/MpJ Versus C57BL/6 Anergic B Cells: Molecular Markers of Autoimmunity.

Authors:  Amy G Clark; Katherine M Mackin; Mary H Foster
Journal:  Biomark Insights       Date:  2008-06-10

Review 6.  Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies.

Authors:  Paolo Fagone; Rosella Ciurleo; Salvo Danilo Lombardo; Carmelo Iacobello; Concetta Ilenia Palermo; Yehuda Shoenfeld; Klaus Bendtzen; Placido Bramanti; Ferdinando Nicoletti
Journal:  Autoimmun Rev       Date:  2020-05-03       Impact factor: 9.754

7.  Characterization of Cellular Heterogeneity and an Immune Subpopulation of Human Megakaryocytes.

Authors:  Cuicui Liu; Dan Wu; Meijuan Xia; Minmin Li; Zhiqiang Sun; Biao Shen; Yiying Liu; Erlie Jiang; Hongtao Wang; Pei Su; Lihong Shi; Zhijian Xiao; Xiaofan Zhu; Wen Zhou; Qianfei Wang; Xin Gao; Tao Cheng; Jiaxi Zhou
Journal:  Adv Sci (Weinh)       Date:  2021-05-26       Impact factor: 16.806

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.